A current examine revealed in JAMA Community Open evaluated outcomes in mechanically ventilated sufferers with pneumonia resulting from coronavirus illness 2019 (COVID-19) or different etiologies.
Examine: Outcomes Amongst Mechanically Ventilated Sufferers With Extreme Pneumonia and Acute Hypoxemic Respiratory Failure From SARS-CoV-2 and Different Etiologies. Picture Credit score: Alina Troeva/Shutterstock
Background
Acute hypoxemic respiratory failure (AHRF) is among the issues of extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) an infection. COVID-19-induced respiratory failure was thought to exhibit the next mortality and distinct physiological phenotype than non-COVID-19 AHRF. This led some clinicians to suggest using non-standard mechanical air flow.
Proponents of COVID-19 AHRF as a singular physiological phenotype have instructed that low tidal quantity air flow could also be pointless and dangerous. Nonetheless, if COVID-19 pneumonia leads to physiology typical of acute respiratory misery syndrome (ARDS), then inclined positioning and low tidal quantity air flow stay the one confirmed interventions for mortality discount.
Concerning the examine
The current examine evaluated key outcomes in sufferers with pneumonia and AHRF resulting from COVID-19 or different etiologies. The analysis crew included people aged 18 or older who had been mechanically ventilated and had extreme pneumonia and AHRF inside two weeks of hospitalization resulting from COVID-19 or different etiologies.
The crew used information on all sufferers assembly the required standards admitted to one of many 5 Johns Hopkins Healthcare System (JHHS) hospitals. COVID-19 sufferers had been hospitalized from March 2020 to June 2021, whereas non-COVID-19 sufferers had been hospitalized with a recorded prognosis of pneumonia between July 2016 and December 2019.
Sufferers with tracheostomy at admission and people with ventilator-related pneumonia had been excluded. The researchers extracted information on baseline demographics, comorbidities, important indicators, respiratory flowsheet parameters, and laboratory findings. The crew computed the sequential organ failure evaluation (SOFA) and CURB-65 (confusion, urea, respiratory fee, blood stress, and age 65 or above) scores on the day of mechanical air flow.
Respiratory parameters of curiosity had been the fraction of impressed oxygen (FiO2), oxygen supply gadgets, and mechanical air flow parameters (mode, plateau stress, set tidal quantity (VT), optimistic end-expiratory stress (PEEP), and complete respiratory fee). The examine’s major end result was in-hospital loss of life inside 90 days.
Secondary outcomes included mechanical air flow parameters within the first week, length, and time to discharge. Physiological outcomes had been the ventilatory ratio within the first week and respiratory system compliance. Variations within the major and secondary outcomes had been in contrast between COVID-19 and non-COVID-19 cohorts.
findings
The analysis crew recognized 719 COVID-19 and 1127 non-COVID-19 sufferers with pneumonia who required mechanical air flow. Most COVID-19 sufferers had been males (61%) and from minoritized racial teams (64%). Most non-COVID-19 sufferers had been males (52%) and White (58.1%). No secular tendencies had been noticed in PEEP, set VT, and plateau stress throughout 2016-19.
Earlier than, COVID-19 sufferers had been extra possible male, diabetic, from a minoritized racial group, and had the next physique mass index (BMI), decrease SOFA rating, and decrease imply ratio of partial stress of oxygen (PaO2) to FiO2 (P /F ratio). COVID-19 sufferers had been intubated for a median of 4.1 days in comparison with 3.4 days for these from the non-COVID-19 cohort.
Additional, sufferers within the COVID-19 cohort had fewer ventilation-free days and longer hospitalization and had been extra more likely to die within the hospital than within the non-COVID-19 cohort. After propensity-score matching, COVID-19 sufferers had been extra more likely to have power kidney illness, immunosuppression, and diabetes and fewer more likely to be a smoker or have power obstructive pulmonary illness (COPD).
Furthermore, COVID-19 sufferers had been extra more likely to be handled with a high-flow nasal cannula and fewer more likely to be handled with non-invasive mechanical air flow. In univariable evaluation, COVID-19 sufferers had been 21% extra more likely to die and fewer more likely to be discharged alive.
Nonetheless, in multivariable evaluation, COVID-19 sufferers had been equally more likely to die as non-COVID-19 sufferers and barely much less more likely to be discharged alive. Within the first seven days of mechanical air flow, sufferers within the COVID-19 cohort had been managed with a decrease VT and better PEEP relative to these within the non-COVID-19 cohort; additionally they had larger plateau stress, decrease ventilatory ratio, and respiratory system compliance.
conclusions
The researchers noticed comparable mortality and longer air flow intervals amongst COVID-19 sufferers with pneumonia relative to non-COVID-19 sufferers. There have been no clinically important variations within the respiratory physiology between cohorts. Notably, sufferers from just one healthcare system had been evaluated, limiting the generalizability of the findings.
The findings indicated an identical mortality fee between mechanically ventilated sufferers resulting from COVID-19 pneumonia and people with pneumonia of different etiologies, and there was no proof of various physiological phenotypes between cohorts.
Journal reference:
- Nolley, E. et al. (2023) “Outcomes Amongst Mechanically Ventilated Sufferers With Extreme Pneumonia and Acute Hypoxemic Respiratory Failure From SARS-CoV-2 and Different Etiologies”, JAMA Community Open, 6(1), p. e2250401. doi: 10.1001/jamanetworkopen.2022.50401.
